Today it was announced that “As a precaution,” the United States recommended a pause in the use of the Johnson & Johnson laboratory’s coronavirus vaccine. This, for fear of blood clots after six cases reported in individuals after receiving the vaccine among the 6.8 million vaccinated with the drug in the country.
In this regard, this morning the Minister of Sciences, Andrés Couve, referred to the issue on Radio Agriculture, indicating that in our country – where this vaccine has not yet been approved, the Institute of Public Health in addition to approving the emergency use of inoculations, maintains a review of international data.
“The studies that we have in Chile that have been published are mainly those of the Catholic University, which provided product quality profiles, also safety and immunogenicity.. In that sense, the adverse effects of the Sinovac vaccine have been very mild, we have not had significant adverse effects “, he indicated.
Thus, he indicated, “We have to be calm that in Chile vaccines are evaluated with very high standards, and the ISP does a task that is not only the authorization, but also a periodic review of the background information that is arriving”.
What was known about the Janssen vaccine, “The Oxford vaccine was already known”, and this leads the ISP “to have a permanent review of the international evidence in order to update this information with respect not only to the efficacy profiles that are emerging as a result of international studies, but mainly of these safety studies.”
“In this sense, the ISP not only authorizes the use of a vaccine but also reviews and issues communications regarding the analysis of the evidence that emerges,” he added.
On what we lack as a country to achieve herd immunity, Couve stressed that “The elderly population behaved really well, and the call now is for the people who are to be vaccinated according to the Minsal calendar to do so.”
According to the calendar, this week it is for people between 49 and 49 years to receive the inoculation.
As explained by the head of the portfolio of Sciences, he “would focus” on two things: on the call for vaccination, and second, put the figures in perspective: To date, he highlights, 4.6 million people have been vaccinated with two doses and we have to reach 15 million people.
After those two doses, add, you have to wait a couple of weeks for people to build immunity.
According to the data they have collected, they have seen “a very significant increase in people who are not older adults “who have required hospitalization”.
“These are very strong indicators that we are all susceptible to this disease,” he said.
“And that is a piece of information that we have, that we have collected it and that is very clear, that this serves as an alert for people to go to be vaccinated now that it is their duty,” he added. “We have made an effort as a country to have the doses. The call is for those who have not done so come to get vaccinated “
–
